A phase I study of 6-azauridine (NSC-32074) in solid tumors.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D014227:Triazines / Q000627:therapeutic use* / Q000633:toxicity
D000970:Antineoplastic Agents; D014227:Triazines